Eric Weinberg - 22 Jan 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Reporting relationship: Chief Commercial Officer
Issuer ticker: RXST
Reported as of: 22 Jan 2024
Net transaction value: -$480,006
SEC form: 4
Accepted by SEC: 22 Jan 2024, 19:50:12 UTC
Prior SEC filing: 10 Jan 2024
Next SEC filing: 02 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Shelley Thunen, as Attorney-in-Fact

Key filing fact

Eric Weinberg filed Form 4 for RxSight, Inc. (RXST) on 22 Jan 2024.

Key facts

This page summarizes Eric Weinberg's Form 4 filing for RxSight, Inc. (RXST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jan 2024, 19:50.

Change

Previous filing in this sequence was filed on 10 Jan 2024.
Current net transaction value: -$480,006.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXST transaction

Common Stock

Sale

Transaction value: $480,006
Shares: -10,000
Change %: -3.1%
Price: $48.00
Shares after: 309,978
Date: 22 Jan 2024
Ownership: See footnote
Footnotes: F1, F2, F3

RXST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,228
Date: 22 Jan 2024
Ownership: Direct

RXST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 925
Date: 22 Jan 2024
Ownership: By fiance

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2023 by the Reporting Person.

Footnote F2

Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $48.00 to $48.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee.